Ying Meng

Ying Meng

Auto-generated profile, based on publicly available information

Ying Meng

Zhejiang Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
XBXueli Bian
Xueli Bian
RLRui Liu
Rui Liu
YMYing Meng
Ying Meng
DXDongming Xing
Dongming Xing
DXDaqian Xu
Daqian Xu
ZLZhimin Lu
Zhimin Lu
Dysregulation in lipid metabolism is among the most prominent metabolic alterations in cancer. Cancer cells harness lipid metabolism to obtain energy, components for biological membranes, and signaling molecules needed for proliferation, survival, invasion, metastasis, and response to the tumor microenvironment impact and cancer therapy. Here, we summarize and discuss current knowledge about the advances made in understanding the regulation of lipid metabolism in cancer cells and introduce different approaches that have been clinically used to disrupt lipid metabolism in cancer therapy.

21 May 2024 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
YMYing Meng
Ying Meng
DGDong Guo
Dong Guo
LLLiming Lin
Liming Lin
HZHong Zhao
Hong Zhao
WXWeiting Xu
Weiting Xu
ZLZhimin Lu
Zhimin Lu

3 May 2024 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
JWJuhong Wang
Juhong Wang
YYYannan Yang
Yannan Yang
FSFei Shao
Fei Shao
YMYing Meng
Ying Meng
DGDong Guo
Dong Guo
ZLZhimin Lu
Zhimin Lu

3 March 2025 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
YDYuran Duan
Yuran Duan
ZHZhiqiang Hu
Zhiqiang Hu
PHPeng Han
Peng Han
BLBo Lei
Bo Lei
SWShuo Wang
Shuo Wang
DXDaqian Xu
Daqian Xu

25 April 2025 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
PZPeixiang Zheng
Peixiang Zheng
ZHZhiqiang Hu
Zhiqiang Hu
YSYuli Shen
Yuli Shen
LGLina Gu
Lina Gu
YOYuan Ouyang
Yuan Ouyang
DXDaqian Xu
Daqian Xu

15 July 2022 in Protein & Cell
Verified
Journal Article
Open access
PDF file
DGDong Guo
Dong Guo
HHHaiyan He
Haiyan He
YMYing Meng
Ying Meng
SLShudi Luo
Shudi Luo
ZLZhimin Lu
Zhimin Lu
The tricarboxylic acid (TCA) cycle identified in 1937 by Hans Adolf Krebs and William Arthur Johnson (also known as the Krebs cycle or citric acid cycle) is a central route for oxidative metabolism to generate cellular energy and intermediates for the biosynthesis of amino acids, lipids, and nucleic acids ( Krebs and Johnson 1937). The TCA cycle connects carbohydrate, fat, and protein metabolism and converts these nutrient catabolism-derived acetyl-CoA into carbon dioxide and water, with the production of reduced NAD+ (NADH), reduced flavin adenine dinucleotide (FADH2), and guanosine triphosphate (GTP). The generated NADH and FADH2 are, in turn, used by the oxidative phosphorylation pathway to generate energy-rich adenosine triphosphate (ATP) ( Chakrabarty and Chandel 2021).